Matthew Ulrickson

8PUBLICATIONS
99CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Feb 11, 2026
Pivekimab Sunirine in Blastic Plasmacytoid Dendritic Cell Neoplasm.

Naveen Pemmaraju, Giovanni Marconi, Pau Montesinos

|Jan 06, 2026
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial.

Paolo Strati, Lori Leslie, Parveen Shiraz

|Oct 16, 2025
Five-Year Follow-Up Analysis of ZUMA-5: Axicabtagene Ciloleucel in Relapsed/Refractory Indolent Non-Hodgkin Lymphoma.

Sattva S Neelapu, Julio C Chavez, Alison R Sehgal

|Sep 25, 2025
Ziftomenib in Relapsed or Refractory NPM1-Mutated AML.

Eunice S Wang, Pau Montesinos, James Foran

|Aug 02, 2024
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium.

Michael D Jain, Jay Y Spiegel, Loretta J Nastoupil

|Jul 08, 2024
Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission.

Mazyar Shadman, Kwang W Ahn, Manmeet Kaur

Pageof 2

Frequent Collaborators

3 joint publications

Olalekan Oluwole

2 joint publications

Jason Westin

2 joint publications

Frederick L Locke

2 joint publications

Armin Ghobadi